BACKGROUND: Emergence of quinolone-resistant Escherichia coli (QREC) is an increasing clinical challenge mostly originating in fecal microbiota. The dynamics of the emergence of QREC in feces from individuals exposed to ciprofloxacin is unknown. METHODS: A total of 48 healthy volunteers received oral ciprofloxacin for 14 days. Fecal specimens were collected on days 0, 8, 14, and 42. Subpopulations of QREC were detected on selective agar, genetically characterized, and compared with quinolone-susceptible E. coli (QSEC) strains collected on different days. RESULTS: On day 42, 34 subjects carried QSEC, and 14 carried QREC. Of the 14 who carried QREC, 9 carried quinolone-susceptible E. coli on day 0, 1 carried E. coli with a lower level of quinolone resistance on day 0, and 4 carried E. coli with similar levels of resistance and RAPD-genotypes on days 0 and 42. No plasmid acquisition and no selection of resistant mutants from the initial microbiota was evidenced in any case. CONCLUSIONS: In QREC emerging under ciprofloxacin pressure in the fecal microbiota, no proof of selection of quinolone-resistant mutants from the initial microbiota was evidenced, suggesting that QREC strains on day 42 were either present at undetectable levels in the initial microbiota or that exogenous acquisition of QREC strains occurred. Clinical Trials Registration. NCT00190151.
BACKGROUND: Emergence of quinolone-resistant Escherichia coli (QREC) is an increasing clinical challenge mostly originating in fecal microbiota. The dynamics of the emergence of QREC in feces from individuals exposed to ciprofloxacin is unknown. METHODS: A total of 48 healthy volunteers received oral ciprofloxacin for 14 days. Fecal specimens were collected on days 0, 8, 14, and 42. Subpopulations of QREC were detected on selective agar, genetically characterized, and compared with quinolone-susceptible E. coli (QSEC) strains collected on different days. RESULTS: On day 42, 34 subjects carried QSEC, and 14 carried QREC. Of the 14 who carried QREC, 9 carried quinolone-susceptible E. coli on day 0, 1 carried E. coli with a lower level of quinolone resistance on day 0, and 4 carried E. coli with similar levels of resistance and RAPD-genotypes on days 0 and 42. No plasmid acquisition and no selection of resistant mutants from the initial microbiota was evidenced in any case. CONCLUSIONS: In QREC emerging under ciprofloxacin pressure in the fecal microbiota, no proof of selection of quinolone-resistant mutants from the initial microbiota was evidenced, suggesting that QREC strains on day 42 were either present at undetectable levels in the initial microbiota or that exogenous acquisition of QREC strains occurred. Clinical Trials Registration. NCT00190151.
Authors: Anna Duse; Karin Persson Waller; Ulf Emanuelson; Helle Ericsson Unnerstad; Ylva Persson; Björn Bengtsson Journal: Appl Environ Microbiol Date: 2016-06-13 Impact factor: 4.792
Authors: Matthew P Kronman; Danielle M Zerr; Xuan Qin; Janet Englund; Cathy Cornell; Jean E Sanders; Jeffrey Myers; Jaipreet Rayar; Jessica E Berry; Amanda L Adler; Scott J Weissman Journal: Diagn Microbiol Infect Dis Date: 2014-06-21 Impact factor: 2.803
Authors: Eva M Kulik; Tuomas Waltimo; Roland Weiger; Irene Schweizer; Krystyna Lenkeit; Elisabeth Filipuzzi-Jenny; Clemens Walter Journal: Clin Oral Investig Date: 2014-12-09 Impact factor: 3.573
Authors: Kang Huang; Chang-Wen Xu; Bo Zeng; Qing-Qing Xia; An-Yun Zhang; Chang-Wei Lei; Zhong-Bin Guan; Han Cheng; Hong-Ning Wang Journal: J Vet Med Sci Date: 2014-06-12 Impact factor: 1.267